Lissa Padnick-Silver

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Rheumatology and therapy

Medicine

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

ACR open rheumatology

Northwestern University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Northwestern University Sep 01 1994 - Sep 01 2000

United States

PHD :: Biomedical Engineering

Washington University in St. Louis Aug 15 1990 - May 09 1994

United States

BSC :: Chemical Engineering

Publications

John Albert, Aaron Broadwell, Lissa Padnick-Silver, Brad Marder, Brian LaMoreaux
Intensive urate-lowering with pegloticase plus methotrexate co-therapy in uncontrolled gout patients with and without chronic kidney disease: A retrospective case series. Medicine 103 (10) (2024)
John Albert, Aaron Broadwell, Lissa Padnick-Silver, Brad Marder, Brian LaMoreaux
Intensive urate-lowering with pegloticase plus methotrexate co-therapy in uncontrolled gout patients with and without chronic kidney disease: A retrospective case series. Medicine 103 (10) (2024)
Anthony J Amatucci, Lissa Padnick-Silver, Brian LaMoreaux, David H Bulbin
Comparison Between Early-Onset and Common Gout: A Systematic Literature Review. Rheumatology and therapy (2023)
John K Botson, Kenneth Saag, Jeff Peterson, Katie Obermeyer, Yan Xin, Brian LaMoreaux, Lissa Padnick-Silver, Supra Verma, Suneet Grewal, Amar Majjhoo, John R P Tesser, Michael E Weinblatt
A Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12-Month Findings. ACR open rheumatology (2023)
Aaron Broadwell, John A Albert, Lissa Padnick-Silver, Brian LaMoreaux
Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout. Rheumatology and therapy 9 (6) (2022)
Naomi Schlesinger, Lissa Padnick-Silver, Brian LaMoreaux
Enhancing the Response Rate to Recombinant Uricases in Patients with Gout. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (2) (2022)
Yao Wang, Anu Sharma, Lissa Padnick-Silver, Megan Francis Sedlak, Robert J Holt, Colleen Foley, Guy Massry, Raymond S Douglas
Trends in Treatment of Active, Moderate-to-Severe Thyroid Eye Disease in the United States. Journal of the Endocrine Society 4 (12) (2020)
Megan Francis Sedlak, Brian LaMoreaux, Lissa Padnick-Silver, Robert J Holt, Alfonso E Bello
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study. Rheumatology and therapy 8 (1) (2020)

Lissa Padnick-Silver.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lissa Padnick-Silver